PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Boston Scientific's PE Ratio without NRI is 35.75. Boston Scientific's 5-Year EBITDA growth rate is 7.40%. Therefore, Boston Scientific's PEG Ratio for today is 4.83.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Boston Scientific's PEG Ratio or its related term are showing as below:
BSX'
s PEG Ratio Range Over the Past 10 Years
Min: 2.38 Med: 4.1 Max: 6.35
Current: 4.83
During the past 13 years, Boston Scientific's highest PEG Ratio was 6.35. The lowest was 2.38. And the median was 4.10.
BSX's PEG Ratio is ranked worse than 77.51% of 249
companies
in the Medical Devices & Instruments industry
Industry Median: 1.8
vs BSX: 4.83
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Boston Scientific PEG Ratio Historical Data
The historical data trend for Boston Scientific's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Boston Scientific's PEG Ratio
For the Medical Devices subindustry, Boston Scientific's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific's PEG Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Boston Scientific's PEG Ratio falls into.
Boston Scientific PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
Boston Scientific's PEG Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Boston Scientific (NYSE:BSX) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Boston Scientific PEG Ratio Related Terms
Thank you for viewing the detailed overview of Boston Scientific's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Boston Scientific (Boston Scientific) Business Description
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSX has been successfully added to your 